# A Study of E7820 in People With Bone Marrow (Myeloid) Cancers

> **NCT05024994** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 12 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Chronic Myelomonocytic Leukemia

## Interventions

- **DRUG:** E7820

## Key facts

- **NCT ID:** NCT05024994
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-13
- **Primary completion:** 2025-06-19
- **Final completion:** 2025-06-19
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05024994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05024994, "A Study of E7820 in People With Bone Marrow (Myeloid) Cancers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05024994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*